[HTML][HTML] The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell …
X Zhang, J Chen, MZ Han, H Huang, E Jiang… - Journal of hematology & …, 2021 - Springer
The consensus recommendations in 2018 from The Chinese Society of Hematology (CSH)
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem …
[HTML][HTML] The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China …
L Xu, H Chen, J Chen, M Han, H Huang, Y Lai… - Journal of hematology & …, 2018 - Springer
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is widely used to treat
malignant hematological neoplasms and non-malignant hematological disorders …
malignant hematological neoplasms and non-malignant hematological disorders …
Aplastic anemia
NS Young - New England Journal of Medicine, 2018 - Mass Medical Soc
Aplastic Anemia | New England Journal of Medicine Skip to main content The New England
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …
Journal of Medicine homepage Advanced Search SEARCH The New England Journal of …
[HTML][HTML] Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group
LP Xu, PH Lu, DP Wu, ZM Sun, QF Liu… - Bone marrow …, 2021 - nature.com
Abstract Between 2008 and 2019, 58,914 hematopoietic stem cell transplantations (HSCTs)
were reported to the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG) …
were reported to the Chinese Blood and Marrow Transplantation Registry Group (CBMTRG) …
[PDF][PDF] 单倍型供者造血干细胞移植治疗重型再生障碍性贫血的单中心研究
杜志丛， 赵艳丽， 曹星玉， 刘德琰， 熊敏… - 临床血液学 …, 2023 - lcxyen.whuhzzs.com
目的: 探讨单倍型造血干细胞移植(haplo-HSCT) 治疗重型再生障碍性贫血(SAA) 的疗效. 方法:
回顾性分析2012 年9 月—2019 年11 月接受HID-HSCT 的120 例儿童和成人SAA …
回顾性分析2012 年9 月—2019 年11 月接受HID-HSCT 的120 例儿童和成人SAA …
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions
YJ Chang, XY Pei, XJ Huang - The Lancet Haematology, 2022 - thelancet.com
In the era of targeted therapies, haematopoietic stem-cell transplantation (HSCT), both
allogeneic and autologous, remains a curative approach for patients with chemosensitive …
allogeneic and autologous, remains a curative approach for patients with chemosensitive …
Diagnosis and treatment of aplastic anemia
Opinion statement Acquired aplastic anemia (AA) is a rare, life-threatening bone marrow
failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte …
failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte …
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies
Abstract Treatment options for newly diagnosed aplastic anemia (AA) patient includes
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …
upfront allogeneic hematopoietic stem cell transplant (HSCT) or immunosuppressive …
Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic …
G ElGohary, R El Fakih, R de Latour… - Bone marrow …, 2020 - nature.com
Aplastic anemia (AA) is a serious hematological disorder, which is solely cured by
hematopoietic stem cell transplantation (HSCT). Haploidentical HSCT is an emerging …
hematopoietic stem cell transplantation (HSCT). Haploidentical HSCT is an emerging …
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working …
In the absence of an HLA-matched donor, the best treatment for acquired aplastic anemia
patients refractory to immunosuppression is unclear. We collected and analyzed data from …
patients refractory to immunosuppression is unclear. We collected and analyzed data from …